These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24446034)

  • 1. Correlation of metabolic tumor volume and 11C-choline uptake with the pathology of prostate cancer: evaluation by use of simultaneously recorded MR and PET images.
    Yoneyama T; Tateishi U; Terauchi T; Inoue T
    Jpn J Radiol; 2014 Mar; 32(3):155-63. PubMed ID: 24446034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
    Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Volumetric Parameters in
    Tseng JR; Yang LY; Lin YC; Liu CY; Pang ST; Hong JH; Yen TC; Wang LJ
    Contrast Media Mol Imaging; 2018; 2018():8945130. PubMed ID: 30532664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
    Chang JH; Lim Joon D; Davis ID; Lee ST; Hiew CY; Esler S; Gong SJ; Wada M; Clouston D; O'Sullivan R; Goh YP; Bolton D; Scott AM; Khoo V
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):438-45. PubMed ID: 25864171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
    Incerti E; Fodor A; Mapelli P; Fiorino C; Alongi P; Kirienko M; Giovacchini G; Busnardo E; Gianolli L; Di Muzio N; Picchio M
    J Nucl Med; 2015 Dec; 56(12):1836-42. PubMed ID: 26405166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
    Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
    Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.
    Yamaguchi T; Lee J; Uemura H; Sasaki T; Takahashi N; Oka T; Shizukuishi K; Endou H; Kubota Y; Inoue T
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):742-8. PubMed ID: 16052370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with
    Sobol I; Zaid HB; Haloi R; Mynderse LA; Froemming AT; Lowe VJ; Davis BJ; Kwon ED; Karnes RJ
    J Urol; 2017 Jan; 197(1):129-134. PubMed ID: 27449262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
    Contractor K; Challapalli A; Barwick T; Winkler M; Hellawell G; Hazell S; Tomasi G; Al-Nahhas A; Mapelli P; Kenny LM; Tadrous P; Coombes RC; Aboagye EO; Mangar S
    Clin Cancer Res; 2011 Dec; 17(24):7673-83. PubMed ID: 22038995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
    Giovacchini G; Picchio M; Garcia-Parra R; Briganti A; Abdollah F; Gianolli L; Schindler C; Montorsi F; Messa C; Fazio F
    J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.
    Ghedini P; Bossert I; Zanoni L; Ceci F; Graziani T; Castellucci P; Ambrosini V; Massari F; Nobili E; Melotti B; Musto A; Zoboli S; Antunovic L; Kirienko M; Chiti A; Mosconi C; Ardizzoni A; Golfieri R; Fanti S; Nanni C
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):751-758. PubMed ID: 29192364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
    Van den Bergh L; Isebaert S; Koole M; Oyen R; Joniau S; Lerut E; Deroose CM; De Keyzer F; Van Poppel H; Haustermans K
    Strahlenther Onkol; 2013 Sep; 189(9):789-95. PubMed ID: 23797481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
    Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA
    Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Choi JY; Yang J; Noworolski SM; Behr S; Chang AJ; Simko JP; Nguyen HG; Carroll PR; Kurhanewicz J; Seo Y
    Radiology; 2017 Feb; 282(2):429-436. PubMed ID: 27513849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
    Mena E; Turkbey B; Mani H; Adler S; Valera VA; Bernardo M; Shah V; Pohida T; McKinney Y; Kwarteng G; Daar D; Lindenberg ML; Eclarinal P; Wade R; Linehan WM; Merino MJ; Pinto PA; Choyke PL; Kurdziel KA
    J Nucl Med; 2012 Apr; 53(4):538-45. PubMed ID: 22343504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
    Kim YI; Cheon GJ; Paeng JC; Cho JY; Kwak C; Kang KW; Chung JK; Kim EE; Lee DS
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1247-56. PubMed ID: 25759164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.
    Souvatzoglou M; Eiber M; Takei T; Fürst S; Maurer T; Gaertner F; Geinitz H; Drzezga A; Ziegler S; Nekolla SG; Rummeny EJ; Schwaiger M; Beer AJ
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1486-99. PubMed ID: 23817684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.